What does CUSIP 91307C102 represent in this 13F holders report?

CUSIP 91307C102 is the security identifier for UTHR - United Therapeutics Corp - Common Stock used to aggregate holder disclosures.

How many institutions held UTHR - United Therapeutics Corp - Common Stock in Q4 2023?

528 institutional investors reported UTHR - United Therapeutics Corp - Common Stock for Q4 2023. Use the holders table for investor-level position and value details.

United Therapeutics Corp - Common Stock (UTHR)

CUSIP: 91307C102

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock
Shares outstanding: 43,898,805
Total 13F shares: 44,516,671
Share change: +136,527
Total reported value: $9,786,687,446
Put/Call ratio: 130%
Price per share: $219.89
Number of holders: 528
Value change: +$24,490,915
Number of buys: 248
Number of sells: 211

Quarterly Holders Quick Answers

What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - United Therapeutics Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024
Previous quarter: Q3 2023

Recent filing periods for CUSIP 91307C102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of UTHR - United Therapeutics Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	12%	5,111,605	$1,154,558,223	—	30 Sep 2023	13F
VANGUARD GROUP INC	13F	Company	11%	4,662,911	$1,053,211,707	—	30 Sep 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	9.4%	4,121,813	$930,993,903	—	30 Sep 2023	13F
Avoro Capital Advisors LLC	13F	Company	6.5%	2,852,500	$644,294,175	—	30 Sep 2023	13F
FMR LLC	13F	Company	5.9%	2,604,789	$588,343,670	—	30 Sep 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	5.1%	2,250,508	$508,322,000	—	30 Sep 2023	13F
STATE STREET CORP	13F	Company	4.3%	1,879,270	$424,470,715	—	30 Sep 2023	13F
JANUS HENDERSON GROUP PLC	13F	Company	2%	876,568	$197,975,929	—	30 Sep 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	830,246	$187,317,463	—	30 Sep 2023	13F
Palo Alto Investors LP	13F	Company	1.3%	575,907	$130,080,114	—	30 Sep 2023	13F
Bank of New York Mellon Corp	13F	Company	1.3%	571,068	$128,987,128	—	30 Sep 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.3%	551,988	$124,678,221	—	30 Sep 2023	13F
Nuveen Asset Management, LLC	13F	Company	1.2%	513,381	$115,957,367	—	30 Sep 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	1.1%	476,588	$107,642,166	—	30 Sep 2023	13F
NORGES BANK	13F	Company	1%	437,969	$98,924,058	—	30 Sep 2023	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	0.98%	430,900	$97,327,445	—	30 Sep 2023	13F
Swedbank AB	13F	Company	0.95%	417,947	$94,401,689	—	30 Sep 2023	13F
ORBIMED ADVISORS LLC	13F	Company	0.92%	401,900	$90,777,153	—	30 Sep 2023	13F
NORTHERN TRUST CORP	13F	Company	0.89%	391,464	$88,419,974	—	30 Sep 2023	13F
LSV ASSET MANAGEMENT	13F	Company	0.87%	383,068	$86,524,000	—	30 Sep 2023	13F
MORGAN STANLEY	13F	Company	0.81%	354,401	$80,048,779	—	30 Sep 2023	13F
FIRST TRUST ADVISORS LP	13F	Company	0.72%	316,162	$71,411,712	—	30 Sep 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.71%	311,307	$70,314,912	—	30 Sep 2023	13F
Paradigm Biocapital Advisors LP	13F	Company	0.7%	307,314	$69,413,013	—	30 Sep 2023	13F
Soleus Capital Management, L.P.	13F	Company	0.65%	287,165	$64,861,959	—	30 Sep 2023	13F
ASSETMARK, INC	13F	Company	0.62%	270,228	$61,036,398	—	30 Sep 2023	13F
Eversept Partners, LP	13F	Company	0.61%	267,903	$60,511,251	—	30 Sep 2023	13F
LOOMIS SAYLES & CO L P	13F	Company	0.6%	265,299	$59,923,000	—	30 Sep 2023	13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC	13F	Individual	0.59%	260,412	$58,819,260	—	30 Sep 2023	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.59%	257,551	$58,173,044	—	30 Sep 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.56%	247,428	$55,886,562	—	30 Sep 2023	13F
Pacer Advisors, Inc.	13F	Company	0.56%	245,061	$55,351,928	—	30 Sep 2023	13F
Invesco Ltd.	13F	Company	0.52%	228,208	$51,545,340	—	30 Sep 2023	13F
Legal & General Group Plc	13F	Company	0.5%	219,603	$49,601,729	—	30 Sep 2023	13F
Iron Triangle Partners LP	13F	Company	0.48%	210,635	$47,576,127	—	30 Sep 2023	13F
Krensavage Asset Management, LLC	13F	Company	0.46%	201,222	$45,450,000	—	30 Sep 2023	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.46%	199,968	$45,167,170	—	30 Sep 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.44%	192,676	$43,519,728	—	30 Sep 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.42%	186,314	$42,082,743	—	30 Sep 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.41%	178,950	$40,419,437	—	30 Sep 2023	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.41%	178,005	$40,205,990	—	30 Sep 2023	13F
Poplar Forest Capital LLC	13F	Company	0.39%	170,903	$38,601,861	—	30 Sep 2023	13F
Eagle Health Investments LP	13F	Company	0.39%	170,838	$38,587,179	—	30 Sep 2023	13F
Pictet Asset Management Holding SA	13F	Company	0.38%	166,978	$37,715,321	—	30 Sep 2023	13F
COMERICA BANK	13F	Company	0.36%	156,587	$35,368,239	—	30 Sep 2023	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.35%	155,628	$35,151,000	—	30 Sep 2023	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.35%	153,416	$34,652,070	—	30 Sep 2023	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.35%	153,160	$34,594,249	—	30 Sep 2023	13F
Swiss National Bank	13F	Company	0.34%	150,655	$34,028,445	—	30 Sep 2023	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.34%	148,600	$33,564,282	—	30 Sep 2023	13F

Institutional Holders of United Therapeutics Corp - Common Stock (UTHR) as of Q4 2023

As of 31 Dec 2023, United Therapeutics Corp - Common Stock (UTHR) was held by 528 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,516,671 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, GEODE CAPITAL MANAGEMENT, LLC, and DIMENSIONAL FUND ADVISORS LP. This page lists 529 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders

503

Q4 2023 holders

528

Holder diff

Investor	Q3 2023 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q3 2023 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.